India Pharma 2026 showcases sectoral transformation through four key plenary discussions
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
A brand from Opella will be part of the official NASA astronaut formulary
The centre offers a full spectrum of FDA-approved services, including physiotherapy, occupational therapy, speech and language therapy, and aqua therapy
The campaign builds on the three-year partnership unveiled earlier this season
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
Subscribe To Our Newsletter & Stay Updated